Transformation of pancreatic nonfunctioning neuroendocrine tumor into metastatic insulinoma: A rare case report
Open Access
- 6 November 2023
- journal article
- research article
- Published by Wiley in Clinical Case Reports
- Vol. 11 (11) , e8152
Abstract
Key Clinical Message: Pancreatic neuroendocrine tumors can be classified as functional or nonfunctional based on hormone secretion. Management of each entity is different, with nonfunctional tumors being treated with traditional chemotherapy while functional tumors respond well to antihormonal therapy and immunologic agents. The conversion of one nonfunctional tumor into a functional tumor is an exceedingly rare event that complicates the overall management of these patients. In this report, we present the case of a 73‐year‐old woman who developed the conversion from a nonfunctional into a functional tumor and discuss the management options considered.Keywords
This publication has 22 references indexed in Scilit:
- Metachronous Hormonal Syndromes in Patients With Pancreatic Neuroendocrine TumorsAnnals of Internal Medicine, 2015
- Intermittent everolimus administration for malignant insulinomaEndocrinology, Diabetes & Metabolism Case Reports, 2014
- Diagnosis and management of insulinomaWorld Journal of Gastroenterology, 2013
- Surgical Management of InsulinomasArchives of Surgery, 2012
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine TumorsNew England Journal of Medicine, 2011
- NANETS Treatment GuidelinesPancreas, 2010
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study GroupJournal of Clinical Oncology, 2009
- Malignant Metastatic Insulinoma—Postoperative Treatment and Follow‐upWorld Journal of Surgery, 2005
- Functioning Insulinoma—Incidence, Recurrence, and Long-Term Survival of Patients: A 60-Year StudyMayo Clinic Proceedings, 1991
- Symptomatic Secondary Hormone Syndromes in Patients with Established Malignant Pancreatic Endocrine TumorsNew England Journal of Medicine, 1988